ArticleCancer diagnosis & prognosis

The Systemic Immune Markers at Diagnosis Can Predict the Survival Benefit in Advanced Breast Cancer.

Shogo Nakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.